75.68
0.67%
-0.51
Pre-market:
78.00
2.32
+3.07%
Centene Corp. stock is currently priced at $75.68, with a 24-hour trading volume of 3.57M.
It has seen a -0.67% decreased in the last 24 hours and a -1.80% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $75.97 pivot point. If it approaches the $75.58 support level, significant changes may occur.
Previous Close:
$76.19
Open:
$76.06
24h Volume:
3.57M
Market Cap:
$40.48B
Revenue:
$154.00B
Net Income/Loss:
$2.70B
P/E Ratio:
17.01
EPS:
4.45
Net Cash Flow:
$7.25B
1W Performance:
+2.62%
1M Performance:
-1.80%
6M Performance:
+10.14%
1Y Performance:
+9.22%
Centene Corp. Stock (CNC) Company Profile
Name
Centene Corp.
Sector
Industry
Phone
314-725-4477
Address
Centene Plaza, 7700 Forsyth Boulevard, St. Louis
Centene Corp. Stock (CNC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jun-20-23 | Initiated | UBS | Neutral |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
Sep-30-22 | Initiated | Argus | Buy |
Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jul-28-22 | Resumed | Barclays | Overweight |
Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Resumed | Bernstein | Outperform |
May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-07-22 | Resumed | Barclays | Overweight |
Jan-06-22 | Resumed | JP Morgan | Overweight |
Dec-14-21 | Initiated | Goldman | Neutral |
Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
Dec-13-21 | Reiterated | BofA Securities | Buy |
Dec-13-21 | Reiterated | Credit Suisse | Neutral |
Dec-13-21 | Reiterated | Mizuho | Neutral |
Dec-13-21 | Reiterated | Oppenheimer | Outperform |
Dec-13-21 | Reiterated | Stephens | Overweight |
Dec-13-21 | Reiterated | Truist | Buy |
Dec-13-21 | Reiterated | Wells Fargo | Overweight |
Dec-13-21 | Reiterated | Wolfe Research | Outperform |
Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
Sep-10-21 | Initiated | Cowen | Outperform |
Jul-09-21 | Initiated | Seaport Global Securities | Buy |
May-19-21 | Initiated | Wells Fargo | Overweight |
May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
Mar-10-21 | Initiated | Mizuho | Neutral |
Jan-21-21 | Resumed | Goldman | Neutral |
Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Jul-01-20 | Initiated | SVB Leerink | Outperform |
Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
Feb-03-20 | Resumed | Evercore ISI | Outperform |
Jan-28-20 | Reiterated | Bernstein | Outperform |
Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
May-10-19 | Upgrade | Citigroup | Neutral → Buy |
Jan-14-19 | Initiated | Stephens | Overweight |
Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Jul-18-18 | Resumed | Citigroup | Neutral |
Dec-18-17 | Reiterated | Jefferies | Buy |
Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
Jun-07-17 | Initiated | Morgan Stanley | Overweight |
May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-05-17 | Initiated | Deutsche Bank | Buy |
Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
Feb-08-17 | Reiterated | Barclays | Overweight |
Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp. Stock (CNC) Latest News
Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
Zacks Investment Research
Humana (HUM) Tops Q1 Earnings and Revenue Estimates
Zacks Investment Research
How Should You Play Centene (CNC) Ahead of Q1 Earnings?
Zacks Investment Research
Unveiling Centene (CNC) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks Investment Research
Analysts Estimate Centene (CNC) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Benzinga
Centene Corp. Stock (CNC) Financials Data
Centene Corp. (CNC) Revenue 2024
CNC reported a revenue (TTM) of $154.00 billion for the quarter ending December 31, 2023, a +6.54% rise year-over-year.
Centene Corp. (CNC) Net Income 2024
CNC net income (TTM) was $2.70 billion for the quarter ending December 31, 2023, a +124.79% increase year-over-year.
Centene Corp. (CNC) Cash Flow 2024
CNC recorded a free cash flow (TTM) of $7.25 billion for the quarter ending December 31, 2023, a +37.99% increase year-over-year.
Centene Corp. (CNC) Earnings per Share 2024
CNC earnings per share (TTM) was $4.91 for the quarter ending December 31, 2023, a +140.69% growth year-over-year.
Centene Corp. Stock (CNC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Robinson Lori Jean | Director |
Feb 13 '24 |
Option Exercise |
54.65 |
10,000 |
546,500 |
21,455 |
Robinson Lori Jean | Director |
Feb 13 '24 |
Sale |
77.41 |
10,000 |
774,100 |
11,455 |
FASOLA KENNETH J | President |
Feb 07 '24 |
Sale |
75.07 |
12,000 |
900,817 |
235,365 |
Robinson Lori Jean | Director |
Apr 27 '23 |
Sale |
66.59 |
1,400 |
93,226 |
8,508 |
About Centene Corp.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Cap:
|
Volume (24h):